Skip to main content
. Author manuscript; available in PMC: 2013 Apr 15.
Published in final edited form as: J Am Geriatr Soc. 2012 Jun 21;60(7):1244–1252. doi: 10.1111/j.1532-5415.2012.04045.x

Figure 3.

Figure 3

Percentage of study participants receiving clinically significant benefits in Short Physical Performance Battery (SPPB) score and 400-m walk speed from 12 months of exercise. (A) Clinically significant improvement and (B) prevention of clinically significant decline expressed as percentage of participants in the PA intervention receiving the benefit minus the percentage in the SA intervention. Data are dichotomized by for angiotensin-converting inhibitor (ACEi) users and all persons not using ACEis. The chosen clinically significant changes were 1 point for SPPB performance and 0.05 m/s for 400-m walking speed, as established in the literature.30,31